| Intracoronary streptokinase after primary percutaneous coronary intervention M Sezer, H Oflaz, T Gören, İ Okçular, B Umman, Y Nişanci, AK Bilge, ... New England Journal of Medicine 356 (18), 1823-1834, 2007 | 223 | 2007 |
| Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT Y Sanli, I Garg, A Kandathil, T Kendi, MJB Zanetti, S Kuyumcu, ... American Journal of Roentgenology 211 (2), 267-277, 2018 | 196 | 2018 |
| Physiological and tumoral uptake of 68Ga-DOTATATE: standardized uptake values and challenges in interpretation S Kuyumcu, ZG Özkan, Y Sanli, E Yilmaz, A Mudun, I Adalet, S Unal Annals of nuclear medicine 27, 538-545, 2013 | 100 | 2013 |
| Increased FDG uptake in breast cancer is associated with prognostic factors Y Sanli, S Kuyumcu, ZG Ozkan, G Işık, H Karanlik, B Guzelbey, ... Annals of nuclear medicine 26, 345-350, 2012 | 84 | 2012 |
| Do circulating long non-coding RNAs (lncRNAs)(LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy? M Fayda, M Isin, M Tambas, M Guveli, R Meral, M Altun, D Sahin, ... Tumor Biology 37, 3969-3978, 2016 | 74 | 2016 |
| The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels Y Sanli, S Kuyumcu, ZG Ozkan, L Kilic, E Balik, C Turkmen, D Has, G Isik, ... Annals of nuclear medicine 26, 551-558, 2012 | 74 | 2012 |
| Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer Y Sanli, C Turkmen, B Bakir, C Iyibozkurt, S Ozel, D Has, E Yilmaz, ... Nuclear medicine communications 33 (5), 509-515, 2012 | 73 | 2012 |
| Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer Y Sanli, S Kuyumcu, O Sanli, F Buyukkaya, A İribaş, G Alcin, ... Annals of nuclear medicine 31, 709-717, 2017 | 67 | 2017 |
| Safety of fibroblast activation protein–targeted radionuclide therapy by a low-dose dosimetric approach using 177Lu-FAPI04 S Kuyumcu, B Kovan, Y Sanli, F Buyukkaya, DH Simsek, ZG Özkan, ... Clinical nuclear medicine 46 (8), 641-646, 2021 | 66 | 2021 |
| Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience A Mudun, Y Sanli, V Ozmen, C Turkmen, S Ozel, A Eroglu, A Igci, E Yavuz, ... Clinical Nuclear Medicine 33 (4), 262-267, 2008 | 64 | 2008 |
| Evidence of prostate-specific membrane antigen expression in hepatocellular carcinoma using 68Ga-PSMA PET/CT S Kuyumcu, D Has-Simsek, R Iliaz, Y Sanli, F Buyukkaya, F Akyuz, ... Clinical nuclear medicine 44 (9), 702-706, 2019 | 50 | 2019 |
| The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid C Turkmen, S Ozturk, SN Unal, B Zulfikar, O Taser, Y Sanli, K Cefle, ... Cancer biotherapy & radiopharmaceuticals 22 (3), 393-399, 2007 | 46 | 2007 |
| The role of peritoneal scintigraphy in the detection of continuous ambulatory peritoneal dialysis complications H Tokmak, A Mudun, C Türkmen, Y Şanli, S Cantez, S Bozfakioğlu Renal failure 28 (8), 709-713, 2006 | 45 | 2006 |
| Tumor heterogeneity on FDG PET/CT and immunotherapy: an imaging biomarker for predicting treatment response in patients with metastatic melanoma Y Sanli, J Leake, A Odu, Y Xi, RM Subramaniam American Journal of Roentgenology 212 (6), 1318-1326, 2019 | 39 | 2019 |
| Monitoring the genotoxic effects of radiosynovectomy with Re‐186 in paediatric age group undergoing therapy for haemophilic synovitis C Turkmen, S Ozturk, SN Unal, B Zulfikar, O Taser, Y Sanli, K Cefle, ... Haemophilia 13 (1), 57-64, 2007 | 37 | 2007 |
| Fibroblast-activated protein inhibitor PET/CT: cancer diagnosis and management S Kuyumcu, Y Sanli, RM Subramaniam Frontiers in oncology 11, 758958, 2021 | 34 | 2021 |
| Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer? DH Simsek, Y Sanli, C Civan, MN Engin, EG Isik, ZG Ozkan, S Kuyumcu Annals of Nuclear Medicine 34, 476-485, 2020 | 32 | 2020 |
| Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to ΔSUVmax, Deauville 5-point scale and IHP criteria EG Isik, S Kuyumcu, R Kebudi, Y Sanli, Z Karakas, FB Cakir, SN Unal Annals of nuclear medicine 31, 660-668, 2017 | 31 | 2017 |
| Update 2018: 18F-FDG PET/CT and PET/MRI in head and neck cancer Y Sanli, K Zukotynski, E Mittra, DL Chen, H Nadel, RD Niederkohr, ... Clinical nuclear medicine 43 (12), e439-e452, 2018 | 28 | 2018 |
| Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory results S Kuyumcu, EG Isik, TO Tiryaki, D Has-Simsek, Y Sanli, F Buyukkaya, ... Annals of nuclear medicine 35 (10), 1147-1156, 2021 | 27 | 2021 |
